Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sponsor withdraws request for committee vote on drug bill after $18 million fiscal estimate
2715563 · March 20, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
Senate Bill 140, presented as a step to reduce drug costs by limiting some utilization management for generics and biosimilars, drew debate over an $18 million fiscal note; sponsor declined to ask the committee for a vote.
Senate Bill 140, introduced by Senator Boyd, drew questions after a consultant reported an $18 million fiscal impact tied to changes in utilization management and pharmacy benefit manager (PBM) practices. Boyd told the Insurance & Commerce Committee he believed the fiscal estimate misinterpreted the bill's exception for pharmacy and therapeutics…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
